Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,572 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07176182RecruitingPhase 2
Chemotherapy with alvenor for rectal cancer with high YWHAB
This trial tests adding the drug alvenor to standard chemotherapy before surgery for rectal cancer patients whose tumors have high levels of a protein called YWHAB. The goal is to see if this combination can improve treatment outcomes.
Guangzhou, GuangdongAges 18–75 - NCT07176208RecruitingPhase 1
THC and alcohol effects on driving in healthy adults
This study looks at how taking THC (the active ingredient in cannabis) with or without alcohol affects your driving and perception. You will take a THC pill and possibly a drink with alcohol, then have your driving tested in a simulator.
West Bend, WisconsinAges 21–55 - NCT07176468Recruiting
Personalized brain stimulation for schizophrenia in real-world settings
This study tests a personalized form of brain stimulation called iTBS for people with schizophrenia. It aims to see if it works in everyday clinical settings.
Hefei, AnhuiAges 18–60 - NCT07176650RecruitingPhase 1
Testing a biosimilar ipilimumab for advanced liver cancer
This trial tests a new version of the immunotherapy drug ipilimumab (called HLX13) against the approved version (YERVOY) for people with advanced liver cancer that cannot be removed by surgery. The goal is to see if the new version works similarly and is as safe.
Glendale, CaliforniaAges 18–65 - NCT07176910Recruiting
Ultrasound-guided treatment for period pain
This trial tests a special ultrasound-guided technique to see if it can reduce pain during period cramps. It is for women with long-term painful periods that are not caused by other conditions.
ChangchunAges 18–25 - NCT07177300RecruitingPhase 4
Hydroxyurea for sickle cell disease in children
This trial tests different ways to start hydroxyurea for children with sickle cell anemia. The goal is to find the safest and most effective approach to help manage symptoms and prevent complications.
Cincinnati, OhioAges 6 months+ - NCT07178600Recruiting
Eye drops for surgery: side effects study
This study looks at how patients react to a common eye drop used before surgery. It helps understand side effects and who might be affected.
Mexico City, Mexico CiyAges 18 years+ - NCT07179679RecruitingPhase 1
Study of a new shot for multiple myeloma
This trial tests a new injectable treatment for people with multiple myeloma that has come back or not responded to previous therapies. It aims to see if the drug is safe and effective.
Chongqing, Chongqing MunicipalityAges 18–75 - NCT07180524Recruiting
Uterine fibroids and their effect on pelvic floor health
This study looks at how uterine fibroids (non-cancerous growths in the uterus) and their surgical removal affect the pelvic floor—the muscles and tissues that support your bladder, bowel, and uterus. It aims to better understand these effects in patients scheduled for either hysterectomy or myomectomy.
Pavia, PaviaAges 35–55 - NCT07184450RecruitingPhase 1
CAR-T cell therapy for children with hard-to-treat rheumatic diseases
This trial tests a new treatment using your child's own immune cells, modified to target B cells and fight severe rheumatic diseases like juvenile dermatomyositis, arthritis, scleroderma, or Sjogren's syndrome. It's for children who haven't improved with standard treatments.
Hangzhou, ZhejiangAges 5 years+ - NCT07185035RecruitingEarly Phase 1
Testing natural killer cells for leftover lung nodules
This trial is testing a new treatment using your own immune cells (called NK cells) to fight leftover high-risk lung nodules that cannot be surgically removed. It is for people who have already had some cancerous nodules removed and are looking for another option.
NanjingAges 18–70 - NCT07187063Recruiting
Using urine tests to reduce checkups for bladder cancer
This trial tests whether monitoring urine tumor DNA can safely reduce how often patients need invasive cystoscopy checkups after initial treatment for non-muscle invasive bladder cancer.
Burlington, MassachusettsAges 18 years+ - NCT07187518Recruiting
Testing a new ultrasound device for bone density
This study tests a new ultrasound device (POROUS R4C) to see if it can accurately estimate bone mineral density. If it works well, it could offer a quick, radiation-free way to check bone health.
BerlinAges 21–55 - NCT07187843Recruiting
Parkinson's type study: brain-first vs body-first
This study looks at how Parkinson's disease affects thinking, movement, and brain health differently depending on whether it starts in the brain or the body first. Participants will have tests and scans to track these differences over time.
Reggio EmiliaAges 18 years+ - NCT07188532Recruiting
Personalized high-dose radiation for Ewing sarcoma
This trial tests a personalized radiation therapy that adjusts the dose based on your tumor. It aims to improve treatment for Ewing sarcoma while limiting side effects.
Phoenix, ArizonaAges 2 years+ - NCT07190638Recruiting
Comparing two kidney surgery stitching methods
This trial tests two different ways to stitch the kidney after removing a tumor. It aims to see which method works better for patients with kidney cancer who need partial kidney removal.
Salvador, Estado de BahiaAges 18 years+ - NCT07191951Recruiting
Adrenal disease study at Shanghai hospital
This study is building a medical database for people with adrenal gland problems like Cushing's syndrome or adrenal tumors. It may help doctors understand these conditions better and improve future care.
ShanghaiAges 18–75 - NCT07192068RecruitingPhase 2
Zanidatamab for HER2-altered solid tumors
This trial tests a drug called zanidatamab in people with certain cancers (endometrial, colorectal, head & neck, non-small cell lung, or sarcoma) that have a specific change in the HER2 gene. It's for those whose cancer has spread or can't be removed and who have tried at least one prior treatment.
AngersAges 18 years+ - NCT07193069Recruiting
Metformin overdose in the ICU – signs and dapagliflozin effects
This study looks at patients who are in the ICU after taking too much metformin (a diabetes drug), sometimes along with another drug called dapagliflozin (Farxiga). The goal is to understand how overdose affects the body and what signs doctors should watch for.
Saint-Denis, FranceAges 18 years+ - NCT07193589RecruitingPhase 2
Testing ZL-82 tablets for moderate to severe eczema
This study tests if an oral tablet called ZL-82 can help people with moderate to severe atopic dermatitis (eczema) that hasn't responded well to other treatments. It aims to find a new option for controlling this chronic skin condition.
Chengdu, SichuanAges 18–75 - NCT07193693Recruiting
Study on why doctors don't use heart imaging during stent placement
This study looks at reasons doctors may or may not use a special camera inside the heart arteries (called OCT or IVUS) during a procedure to open blocked arteries. It may help understand how to improve care for people with complex blockages.
BergamoAges 18 years+ - NCT07195253Recruiting
Down syndrome and sleep apnea study in infants
This study looks at mouth and face features and sleep apnea in 6-month-old infants with Down syndrome. It may help doctors understand and treat sleep problems better.
BronAges 5 months–6 months - NCT07195500Recruiting
Imaging scans for neuroblastoma and related tumors
This trial uses special PET/CT or SPECT/CT scans that light up certain types of tumor cells (neuroblastoma and pheochromocytoma/paraganglioma). The scans help doctors see where the cancer is, how far it has spread, and whether treatment is working.
Nanjing, JiangsuAges 6 months+ - NCT07195994Recruiting
Study of an investigational product with or without semaglutide for blood sugar
This trial tests an investigational product to see how well it controls blood sugar in adults with prediabetes or type 2 diabetes. Some participants will also take the diabetes medication semaglutide to compare effects.
London, OntarioAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,572 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.